Surmodics | Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 7.51B 560M 2025-09
Align Technology USD 1B 103.43M 2025-09
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
Baxter International USD 1.73B 40M 2025-09
Boston Scientific USD 1.28B 741M 2025-09
EDAP TMS EUR 29.84M 4.35M 2024-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Haemonetics USD 363.37M 66.94M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
J&J USD 18.23B 10.35B 2025-09
Merit Medical Systems USD 392.46M 50.64M 2025-09
Mesa Laboratories USD 28.98M 8.55M 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Option Care Health USD 309.82M 111M 2025-09
Stryker USD 3.26B 881M 2025-09
Surmodics USD 36.11M 11.81M 2024-09
Trinity Biotech USD 1.34M 3.83M 2025-09


Surmodics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.